Molecular genetics and immunohistochemistry of renal tumours: Translation into clinical practice

Fang Ming Deng, Ming Zhou

Research output: Contribution to journalReview article

Abstract

Renal cell carcinomas comprise a heterogeneous group of tumours with diverse clinicopathological and molecular characteristics as well as therapeutic options. Accurate diagnosis and classification are critical for patient management and prognosis prediction. They have traditionally been classified according to histopathological features. Recent advances in high throughput technologies, including next generation sequencing, have enabled us to search genome-wide for genomic, transcriptomic and proteomic changes in large number of renal cancer specimens. Studies have demonstrated that different histological subtypes harbour unique genomic and epigenetic alterations and gene expression and protein profile that can be integrated with clinicopathological features for diagnosis, classification, prognosis and individualized treatment and "n-of-1" trials. This review will discuss the immunoprofiles of major renal cell carcinoma subtypes, immunohistochemical markers that are commonly used in clinical laboratories, and recent genomic and epigenetic discoveries in renal cell carcinomas.

Original languageEnglish (US)
Pages (from-to)73-79
Number of pages7
JournalDiagnostic Histopathology
Volume22
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Renal Cell Carcinoma
Molecular Biology
Immunohistochemistry
Kidney
Epigenomics
Neoplasms
Kidney Neoplasms
Transcriptome
Proteomics
Genome
Technology
Therapeutics
Proteins

Keywords

  • Diagnosis
  • Epigenetics
  • Genomics
  • Immunohistochemistry
  • Kidney
  • Next generation sequencing
  • Proteomics
  • Renal cell carcinoma
  • Transcriptomics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Molecular genetics and immunohistochemistry of renal tumours : Translation into clinical practice. / Deng, Fang Ming; Zhou, Ming.

In: Diagnostic Histopathology, Vol. 22, No. 2, 01.02.2016, p. 73-79.

Research output: Contribution to journalReview article

@article{d4d233712b864f7889281fdd1d46504c,
title = "Molecular genetics and immunohistochemistry of renal tumours: Translation into clinical practice",
abstract = "Renal cell carcinomas comprise a heterogeneous group of tumours with diverse clinicopathological and molecular characteristics as well as therapeutic options. Accurate diagnosis and classification are critical for patient management and prognosis prediction. They have traditionally been classified according to histopathological features. Recent advances in high throughput technologies, including next generation sequencing, have enabled us to search genome-wide for genomic, transcriptomic and proteomic changes in large number of renal cancer specimens. Studies have demonstrated that different histological subtypes harbour unique genomic and epigenetic alterations and gene expression and protein profile that can be integrated with clinicopathological features for diagnosis, classification, prognosis and individualized treatment and {"}n-of-1{"} trials. This review will discuss the immunoprofiles of major renal cell carcinoma subtypes, immunohistochemical markers that are commonly used in clinical laboratories, and recent genomic and epigenetic discoveries in renal cell carcinomas.",
keywords = "Diagnosis, Epigenetics, Genomics, Immunohistochemistry, Kidney, Next generation sequencing, Proteomics, Renal cell carcinoma, Transcriptomics",
author = "Deng, {Fang Ming} and Ming Zhou",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.mpdhp.2016.01.007",
language = "English (US)",
volume = "22",
pages = "73--79",
journal = "Diagnostic Histopathology",
issn = "1756-2317",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Molecular genetics and immunohistochemistry of renal tumours

T2 - Translation into clinical practice

AU - Deng, Fang Ming

AU - Zhou, Ming

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Renal cell carcinomas comprise a heterogeneous group of tumours with diverse clinicopathological and molecular characteristics as well as therapeutic options. Accurate diagnosis and classification are critical for patient management and prognosis prediction. They have traditionally been classified according to histopathological features. Recent advances in high throughput technologies, including next generation sequencing, have enabled us to search genome-wide for genomic, transcriptomic and proteomic changes in large number of renal cancer specimens. Studies have demonstrated that different histological subtypes harbour unique genomic and epigenetic alterations and gene expression and protein profile that can be integrated with clinicopathological features for diagnosis, classification, prognosis and individualized treatment and "n-of-1" trials. This review will discuss the immunoprofiles of major renal cell carcinoma subtypes, immunohistochemical markers that are commonly used in clinical laboratories, and recent genomic and epigenetic discoveries in renal cell carcinomas.

AB - Renal cell carcinomas comprise a heterogeneous group of tumours with diverse clinicopathological and molecular characteristics as well as therapeutic options. Accurate diagnosis and classification are critical for patient management and prognosis prediction. They have traditionally been classified according to histopathological features. Recent advances in high throughput technologies, including next generation sequencing, have enabled us to search genome-wide for genomic, transcriptomic and proteomic changes in large number of renal cancer specimens. Studies have demonstrated that different histological subtypes harbour unique genomic and epigenetic alterations and gene expression and protein profile that can be integrated with clinicopathological features for diagnosis, classification, prognosis and individualized treatment and "n-of-1" trials. This review will discuss the immunoprofiles of major renal cell carcinoma subtypes, immunohistochemical markers that are commonly used in clinical laboratories, and recent genomic and epigenetic discoveries in renal cell carcinomas.

KW - Diagnosis

KW - Epigenetics

KW - Genomics

KW - Immunohistochemistry

KW - Kidney

KW - Next generation sequencing

KW - Proteomics

KW - Renal cell carcinoma

KW - Transcriptomics

UR - http://www.scopus.com/inward/record.url?scp=84958559558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958559558&partnerID=8YFLogxK

U2 - 10.1016/j.mpdhp.2016.01.007

DO - 10.1016/j.mpdhp.2016.01.007

M3 - Review article

AN - SCOPUS:84958559558

VL - 22

SP - 73

EP - 79

JO - Diagnostic Histopathology

JF - Diagnostic Histopathology

SN - 1756-2317

IS - 2

ER -